News & Trends - MedTech & Diagnostics
National Reconstruction Fund is ‘open for business’
MedTech & Diagnostics News: The $15 billion National Reconstruction Fund (NRF) is now officially “open for business”, earmarking a substantial […]
MoreNews & Trends - Biotechnology
Parliament House hosts biotech policy forum
Biotech News: Canberra’s Parliament House hosted biotech leaders for strategic discussions and insightful presentations. The AusBiotech annual Policy Forum marked […]
MoreDigital & Innovation
Australia to unveil AI healthcare policy roadmap to align with international standards
Digital & Innovation: A significant stride towards the ethical and secure integration of artificial intelligence (AI) in the healthcare system […]
MoreLeadership & Management
Does a public servant in the Department of Health deserve $850,000 a year?
Is it ethically justifiable to defend exorbitant salaries for a select few when a considerable portion of Australians are grappling […]
MoreHuman Resources
Gilead and AstraZeneca earn recognition for LGBTQ workplace inclusion
Human Resources: In a reaffirmation of its ongoing commitment to fostering an inclusive workplace, Gilead Sciences Australia has earned recognition […]
MoreMedical
$100 million research investment to be an immunology game-changer
Medical: A cutting-edge immunology research centre at the Walter and Eliza Hall Institute (WEHI) has been announced by the Snow […]
MoreMarketing & Strategy
Prime Awards 2023 winners announced
Marketing & Strategy: The 19th annual PRIME Awards was celebrated on Thursday 9th November, recognising excellence in healthcare marketing and […]
MoreSales
PRIME Awards revamps sales categories to align with evolving models of HCP engagement
2023 brings more exciting changes to the PRIME Awards. After careful evaluation and review, the Sales award categories have been […]
MoreCommunication
Breaking the chains: Unveiling Australia’s media monopoly crisis
A Senate committee is considering a proposal for a parliamentary commission of inquiry into the Murdoch media empire and media […]
MoreBest Practice
Is there an art to mastering workplace relationships with anyone?
In a world where work relationships may feel like a game of chance, there’s an approach that promises to change […]
MoreMarket Research & Insights
Are persistent gaps undermining sustainability reporting progress in Australia?
In a stride toward environmental sustainability, the majority of Australia’s ASX200 companies are embracing mandatory climate reporting, setting a promising […]
MoreESG
New report calls on policy integration of sustainability in medical device and pharmaceutical registrations and funding
ESG: Increasing pressures from diverse stakeholder groups, spanning policymakers, investors, customers, and employees, have elevated Environmental, Social, and Governance (ESG) […]
More
Recent Posts in Pharma, MedTech & Biotech
Government’s long-awaited response to The New Frontier report unveiled after two-year wait
December 1, 2023
in News & Trends - Pharmaceuticals
Gilead welcomes HIV Taskforce report and celebrates the ‘unsung heroes’
December 1, 2023
in News & Trends - Pharmaceuticals
AbbVie secures PBS listing of first therapy for Crohn’s disease in seven years
December 1, 2023
in News & Trends - Pharmaceuticals
New report calls on policy integration of sustainability in medical device and pharmaceutical registrations and funding
November 30, 2023
in ESG
National Reconstruction Fund is ‘open for business’
November 30, 2023
in News & Trends - MedTech & Diagnostics
‘Overpriced medical devices are a key factor in driving higher premiums’, says Private Healthcare Australia amid escalating management expenses
November 30, 2023
in News & Trends - MedTech & Diagnostics
Dermatologists raise concerns over safety, care fragmentation and conflict of interest in pharmacy pilot expansion
November 30, 2023
in News & Trends - Pharmaceuticals
ResMed issues safety warning, one year after competitor alert
November 30, 2023
in News & Trends - MedTech & Diagnostics
Senator Ruston and Dr Freelander unveil new report, recognising ‘value’ of pathology and diagnostics
November 28, 2023
in News & Trends - MedTech & Diagnostics
Is the government gearing up to release the long-awaited response to The New Frontier report?
November 28, 2023
in News & Trends - Pharmaceuticals
Government considers regulation overhaul in genetic testing amid discrimination concerns
November 28, 2023
in News & Trends - MedTech & Diagnostics
Does a public servant in the Department of Health deserve $850,000 a year?
November 27, 2023
in Leadership & Management
Inquiry to scrutinise healthcare funding amid escalating ‘crisis’ across states
November 27, 2023
in News & Trends - MedTech & Diagnostics
Is the nation building on the foundations of CAR T therapy?
November 27, 2023
in News & Trends - Pharmaceuticals
Research supports neoadjuvant use of Novartis LuPSMA in prostate cancer
November 27, 2023
in News & Trends - Pharmaceuticals
Surging costs force Australians to skip GP visits, delay vital medicines and limit hospital care
November 23, 2023
in News & Trends - Pharmaceuticals
Experts urge vigilance and updated vaccination for endemic Covid-19
November 23, 2023
in News & Trends - Pharmaceuticals
Patient Voice Hub redefines consumer engagement with PBAC and MSAC
November 23, 2023
in News & Trends - Pharmaceuticals
MTAA and academic experts applaud Cyber Security Strategy amid escalating threats
November 23, 2023
in News & Trends - MedTech & Diagnostics
Follow Us
Partner with us
News & Trends - Pharmaceuticals
Government’s long-awaited response to The New Frontier report unveiled after two-year wait
Pharma News: The Albanese Government has tabled its response to the House of Reps inquiry and The New Frontier report […]
MoreNews & Trends - Pharmaceuticals
Gilead welcomes HIV Taskforce report and celebrates the ‘unsung heroes’
Pharma News: On World AIDS Day, the National Association of People with HIV Australia (NAPWHA) and Gilead Sciences Australia have […]
MoreNews & Trends - Pharmaceuticals
AbbVie secures PBS listing of first therapy for Crohn’s disease in seven years
Pharma News: AbbVie’s Rinvoq (upadacitinib), a once-daily tablet, has been officially listed on the Pharmaceutical Benefits Scheme (PBS) for adult […]
MoreESG
New report calls on policy integration of sustainability in medical device and pharmaceutical registrations and funding
ESG: Increasing pressures from diverse stakeholder groups, spanning policymakers, investors, customers, and employees, have elevated Environmental, Social, and Governance (ESG) […]
More